Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- Latest filing
- Aug 14, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed May 15, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 93
- +4 vs. Q4 2023
- Portfolio value
- $617.5M
- +$78.9M (+14.7%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,889,700 | $26.7M | 4.3% | −579,400−23.5% | Reduced | History |
| SNYSanofi | SPONSORED ADR | 499,515 | $24.3M | 3.9% | 00.0% | Unchanged | History |
| NICENICE Ltd. | SPONSORED ADR | 85,881 | $22.4M | 3.6% | +18,163+26.8% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 281,671 | $19.7M | 3.2% | +57,851+25.8% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 812,964 | $19.3M | 3.1% | +40,000+5.2% | Added | History |
| BBIOBridgeBio Pharma, Inc. | COM | 585,956 | $18.1M | 2.9% | +303,810+107.7% | Added | History |
| BIIBBiogen Inc. | COM | 70,646 | $15.2M | 2.5% | +24,300+52.4% | Added | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 505,242 | $14.8M | 2.4% | +505,242 | New | History |
| CATXPerspective Therapeutics, Inc. | COM | 12,443,621 | $14.8M | 2.4% | +12,417,950+48,373.5% | Added | History |
| MRKMerck & Co., Inc. | Stock | 103,600 | $13.7M | 2.2% | −20,000−16.2% | Reduced | History |
| KURAKura Oncology, Inc. | COM | 610,826 | $13.0M | 2.1% | −92,461−13.1% | Reduced | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 190,060 | $12.9M | 2.1% | +10,000+5.6% | Added | History |
| SSentinelOne, Inc. | CL A | 550,818 | $12.8M | 2.1% | +337,400+158.1% | Added | History |
| JNJJohnson & Johnson | Stock | 79,831 | $12.6M | 2.0% | 00.0% | Unchanged | History |
| METAMeta Platforms, Inc. | Stock | 25,439 | $12.4M | 2.0% | −8,864−25.8% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 276,996 | $11.6M | 1.9% | −38,648−12.2% | Reduced | History |
| MSFTMicrosoft Corp | Stock | 27,548 | $11.6M | 1.9% | +3,700+15.5% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 238,544 | $11.1M | 1.8% | +37,500+18.7% | Added | History |
| LLYEli Lilly & Co | Stock | 14,190 | $11.0M | 1.8% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 177,139 | $10.8M | 1.8% | +177,139 | New | History |
| NVONovo Nordisk A S | ADR | 83,080 | $10.7M | 1.7% | −10,000−10.7% | Reduced | History |
| Cybin Ord23256X100 | COM | 25,581,395 | $10.6M | 1.7% | +25,581,395 | New | – |
| INZYInozyme Pharma, Inc. | COM | 1,372,907 | $10.5M | 1.7% | −190,000−12.2% | Reduced | History |
| FROGJFrog Ltd | Stock | 224,381 | $9.92M | 1.6% | +114,476+104.2% | Added | History |
| AMZNAmazon Com Inc | Stock | 54,432 | $9.82M | 1.6% | −1,244−2.2% | Reduced | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 449,041 | $9.57M | 1.6% | −636,598−58.6% | Reduced | History |
| PHVSPharvaris N.V. | COM | 392,877 | $9.08M | 1.5% | +147,877+60.4% | Added | History |
| MLYSMineralys Therapeutics, Inc. | COM | 658,803 | $8.51M | 1.4% | −84,788−11.4% | Reduced | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 492,627 | $8.14M | 1.3% | −20,373−4.0% | Reduced | History |
| GLBEGlobal-E Online Ltd. | SHS | 208,784 | $7.59M | 1.2% | −61,010−22.6% | Reduced | History |
| WIXWix.com Ltd. | SHS | 52,877 | $7.27M | 1.2% | −4,600−8.0% | Reduced | History |
| SRPTSarepta Therapeutics, Inc. | COM | 55,614 | $7.20M | 1.2% | +43,114+344.9% | Added | History |
| IMTXImmatics N.V. | SHS | 666,111 | $7.00M | 1.1% | +45,000+7.2% | Added | History |
| ABBVAbbVie Inc. | Stock | 38,000 | $6.92M | 1.1% | −8,000−17.4% | Reduced | History |
| OTLKOutlook Therapeutics, Inc. | Stock | 571,429 | $6.82M | 1.1% | +571,429 | New | History |
| MRUSMerus N.V. | COM | 149,333 | $6.72M | 1.1% | −81,000−35.2% | Reduced | History |
| AMATApplied Materials Inc | Stock | 32,000 | $6.60M | 1.1% | +32,000 | New | History |
| CAMTCamtek Ltd | ORD | 74,909 | $6.28M | 1.0% | +74,909 | New | History |
| NVMINova Ltd. | COM | 35,106 | $6.23M | 1.0% | −96,894−73.4% | Reduced | History |
| TSEMTower Semiconductor Ltd | SHS NEW | 179,600 | $6.01M | 1.0% | −348,700−66.0% | Reduced | History |
| ETNB89bio, Inc. | COM | 515,882 | $6.00M | 1.0% | +107,208+26.2% | Added | History |
| VIGLVigil Neuroscience, Inc. | COM | 1,730,414 | $5.90M | 1.0% | +1,195,294+223.4% | Added | History |
| ENPHEnphase Energy, Inc. | Stock | 47,183 | $5.71M | 0.9% | +12,383+35.6% | Added | History |
| VTYXVentyx Biosciences, Inc. | COM | 992,749 | $5.46M | 0.9% | +812,749+451.5% | Added | History |
| TBLATaboola.com Ltd. | ORD SHS | 1,191,070 | $5.29M | 0.9% | −533,878−31.0% | Reduced | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 162,161 | $5.17M | 0.8% | +162,161 | New | History |
| INCYIncyte Corp | COM | 89,556 | $5.10M | 0.8% | 00.0% | Unchanged | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 183,722 | $4.95M | 0.8% | −7,061−3.7% | Reduced | History |
| NVSNovartis AG | ADR | 50,000 | $4.84M | 0.8% | −10,000−16.7% | Reduced | History |
| CPRXCatalyst Pharmaceuticals, Inc. | COM | 288,000 | $4.59M | 0.7% | +288,000 | New | History |
| GSKGSK plc | ADR | 100,000 | $4.29M | 0.7% | 00.0% | Unchanged | History |
| VTGNVistagen Therapeutics, Inc. | COM | 808,550 | $4.27M | 0.7% | 00.0% | Unchanged | History |
| APLTApplied Therapeutics, Inc. | COM | 619,029 | $4.21M | 0.7% | +619,029 | New | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 626,810 | $4.06M | 0.7% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 160,445 | $4.05M | 0.7% | +160,445 | New | History |
| SHL Telemedicine Ltd78423T200 | ADS | 632,456 | $3.86M | 0.6% | 00.0% | Unchanged | – |
| PLRXPliant Therapeutics, Inc. | COM | 258,554 | $3.85M | 0.6% | +65,000+33.6% | Added | History |
| PMNProMIS Neurosciences Inc. | COM | 1,834,047 | $3.50M | 0.6% | +50.0% | Added | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 70,269 | $3.46M | 0.6% | −100,001−58.7% | Reduced | History |
| ALECAlector, Inc. | COM | 560,000 | $3.37M | 0.5% | +560,000 | New | History |
| IRONDisc Medicine, Inc. | COM | 48,886 | $3.04M | 0.5% | +48,886 | New | History |
| AAPLApple Inc. | Stock | 17,500 | $3.00M | 0.5% | +17,500 | New | History |
| ENLTEnlight Renewable Energy Ltd. | SHS | 169,280 | $2.86M | 0.5% | 00.0% | Unchanged | History |
| SEDGSolaredge Technologies, Inc. | COM | 40,175 | $2.85M | 0.5% | −7,825−16.3% | Reduced | History |
| RZLTRezolute, Inc. | COM NEW | 996,710 | $2.54M | 0.4% | 00.0% | Unchanged | History |
| QCOMQualcomm Inc | Stock | 15,000 | $2.54M | 0.4% | +15,000 | New | History |
| PFEPfizer Inc | Stock | 90,000 | $2.50M | 0.4% | 00.0% | Unchanged | History |
| ACADAcadia Pharmaceuticals Inc | COM | 125,000 | $2.31M | 0.4% | +125,000 | New | History |
| ELEVElevation Acquisition Group Inc. | COM | 430,000 | $2.21M | 0.4% | −470,000−52.2% | Reduced | History |
| ESTCElastic N.V. | ORD SHS | 20,000 | $2.00M | 0.3% | +20,000 | New | History |
| AMDAdvanced Micro Devices Inc | Stock | 11,000 | $1.99M | 0.3% | −39,387−78.2% | Reduced | History |
| CGENCompugen Ltd | ORD | 769,239 | $1.98M | 0.3% | 00.0% | Unchanged | History |
| NTRNutrien Ltd. | COM | 35,730 | $1.94M | 0.3% | +35,730 | New | History |
| KZRKezar Life Sciences, Inc. | COM | 2,051,676 | $1.85M | 0.3% | 00.0% | Unchanged | History |
| APREAprea Therapeutics, Inc. | COM NEW | 270,000 | $1.81M | 0.3% | +270,000 | New | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 44,841 | $1.78M | 0.3% | −190,000−80.9% | Reduced | History |
| FIVNFive9, Inc. | COM | 27,500 | $1.71M | 0.3% | +12,500+83.3% | Added | History |
| CRGXCARGO Therapeutics, Inc. | COM | 75,000 | $1.67M | 0.3% | 00.0% | Unchanged | History |
| ATXSAstria Therapeutics, Inc. | COM | 112,842 | $1.59M | 0.3% | −1,038,303−90.2% | Reduced | History |
| PRMEPrime Medicine, Inc. | COM | 205,242 | $1.44M | 0.2% | +131,262+177.4% | Added | History |
| UPWKUpwork, Inc | COM | 117,000 | $1.43M | 0.2% | −135,784−53.7% | Reduced | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 35,000 | $1.37M | 0.2% | +35,000 | New | History |
| AVGOBroadcom Inc. | Stock | 1,001 | $1.33M | 0.2% | −799−44.4% | Reduced | History |
| GERNGeron Corp | COM | 384,356 | $1.27M | 0.2% | +384,356 | New | History |
| LVTXLAVA Therapeutics NV | SHS | 367,582 | $1.22M | 0.2% | +367,582 | New | History |
| GOSSGossamer Bio, Inc. | COM | 1,027,134 | $1.21M | 0.2% | −310,956−23.2% | Reduced | History |
| VRNSVaronis Systems Inc | COM | 20,000 | $943.4K | 0.2% | +20,000 | New | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 267,250 | $759.0K | 0.1% | +83,600+45.5% | Added | History |
| ICLICL Group Ltd. | SHS | 130,475 | $702.0K | 0.1% | −289,525−68.9% | Reduced | History |
| RNACCartesian Therapeutics, Inc. | COM | 25,071 | $488.9K | 0.1% | −727,066−96.7% | Reduced | History |
| ANROAlto Neuroscience, Inc. | COM SHS | 30,500 | $468.2K | 0.1% | +30,500 | New | History |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 100,000 | $270.0K | <0.1% | 00.0% | Unchanged | – |
| ARBEArbe Robotics Ltd. | COM | 43,165 | $90.2K | <0.1% | 00.0% | Unchanged | History |
Options (11)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $44.2M |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $36.1M | – |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | – | $2.99M |
| RAREUltragenyx Pharmaceutical Inc. | COM | – | $2.57M |
| SEDGSolaredge Technologies, Inc. | COM | – | $1.90M |
| ACADAcadia Pharmaceuticals Inc | COM | – | $1.85M |
| IRONDisc Medicine, Inc. | COM | – | $1.56M |
| BBIOBridgeBio Pharma, Inc. | COM | – | $1.55M |
| INSMINSMED Inc | COM PAR $.01 | – | $762.4K |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | – | $681.6K |
| ANNXAnnexon, Inc. | COM | $81.7K | – |
Sold out since Q4 2023 (19)
Positions held at the end of Q4 2023 that are gone from this filing.
| Security | Class | Shares in Q4 2023 | Value in Q4 2023 | % of portfolio in Q4 2023 | History |
|---|---|---|---|---|---|
| INBXInhibrx Biosciences, Inc. | COM | 226,551 | $8.61M | 1.6% | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 328,986 | $7.33M | 1.4% | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 36,230 | $6.93M | 1.3% | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 27,767 | $6.42M | 1.2% | History |
| JSPRJasper Therapeutics, Inc. | COM | 713,063 | $5.63M | 1.0% | History |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 502,936 | $5.05M | 0.9% | – |
| PANWPalo Alto Networks Inc | Stock | 16,585 | $4.89M | 0.9% | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 144,899 | $4.43M | 0.8% | History |
| PTCTPTC Therapeutics, Inc. | COM | 136,525 | $3.76M | 0.7% | History |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 1,228,126 | $1.78M | 0.3% | History |
| GILDGilead Sciences, Inc. | Stock | 20,000 | $1.62M | 0.3% | History |
| COGTCogent Biosciences, Inc. | COM | 259,201 | $1.52M | 0.3% | History |
| ORICOric Pharmaceuticals, Inc. | COM | 126,800 | $1.17M | 0.2% | History |
| APGEApogee Therapeutics, Inc. | COM | 30,000 | $838.2K | 0.2% | History |
| MDWDMediWound Ltd. | SHS NEW | 48,980 | $498.1K | 0.1% | History |
| MORFMorphic Holding, Inc. | COM | 14,952 | $431.8K | 0.1% | History |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 48,511 | $274.1K | 0.1% | History |
| REPLReplimune Group, Inc. | COM | 16,096 | $135.7K | <0.1% | History |
| Freeline Therapeutics Hldgs35655L206 | SPONSORED ADS | 16,445 | $104.8K | <0.1% | – |